JDG — Judges Scientific Income Statement
0.000.00%
- £329.69m
- £375.49m
- £145.80m
Annual income statement for Judges Scientific, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 91.3 | 113 | 136 | 134 | 146 |
| Cost of Revenue | |||||
| Gross Profit | 58 | 77.1 | 94.8 | 92 | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 75.7 | 95.1 | 114 | 117 | 132 |
| Operating Profit | 15.6 | 18.1 | 21.7 | 16.8 | 13.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 14.9 | 16 | 13.4 | 13 | 8.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 12.9 | 12.8 | 9.9 | 10.8 | 6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 12.7 | 12.4 | 9.5 | 10.4 | 5.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 12.7 | 12.4 | 9.5 | 10.4 | 5.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.11 | 2.32 | 1.45 | 2.05 | 0.977 |
| Dividends per Share |